Arq. Bras. Cardiol. 2019; 112(1): 11

Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia

Marcia Kiyomi Koike ORCID logo

DOI: 10.5935/abc.20180269

This Short Editorial is referred by the Research article "Rapamycin Combined with ?-Cyanoacrylate Contributes to Inhibiting Intimal Hyperplasia in Rat Models".

Myocardial revascularization (CABG) surgery remains one of the main therapies for coronary disease. However, vascular disease that follows CABG remains a challenge to medicine. The mechanical, molecular and cellular changes undergone by the venous vascular graft when inserted into the coronary artery flow culminate in thrombosis, intimal hyperplasia, and atherosclerotic process, and end with restenosis.,

CABG experimental models were crucial to the understanding of mechanisms present in the course of vascular disease. The vascular graft model with anastomosis of the external jugular vein with the carotid artery represents an experimental model of vascular disease similar to that occurring after CABG. Pigs, rabbits, and rats may be used in this model because of protocol reproducibility, cost, and benefit.,

[…]

Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia

Comments

Skip to content